第一单位：
Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
作者：
Felix,Schneider [1]
;
Adam,Kaczorowski [1]
;
Christina,Jurcic [1]
;
Martina,Kirchner [2]
;
Constantin,Schwab [2]
;
Viktoria,Schütz [3]
;
Magdalena,Görtz [3]
;
Stefanie,Zschäbitz [4]
;
Dirk,Jäger [4]
;
Albrecht,Stenzinger [2]
;
Markus,Hohenfellner [3]
;
Stefan,Duensing [5]
;
Anette,Duensing [6]
作者单位：
Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
[1]
Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, D-69120 Heidelberg, Germany.
[2]
Department of Urology, University Hospital Heidelberg, and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 420, D-69120 Heidelberg, Germany.
[3]
Department of Medical Oncology, University Hospital Heidelberg, and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, D-69120 Heidelberg, Germany.
[4]
Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.;Department of Urology, University Hospital Heidelberg, and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 420, D-69120 Heidelberg, Germany.
[5]
Department of Urology, University Hospital Heidelberg, and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 420, D-69120 Heidelberg, Germany.;Cancer Therapeutics Program, UPMC Hillman Cancer Center, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.;Department of Pathology, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA 15213, USA.;Precision Oncology of Urological Malignancies, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
[6]
DOI
10.3390/cancers15205050
PMID
37894418
发布时间
2023-10-30
换一批
